EFFECT OF RANIRESTAT, A NEW ALDOSE REDUCTASE INHIBITOR, ON DIABETIC RETINOPATHY IN SDT RATS

被引：0
|
作者：
Toyoda, Fumihiko [1 ]
Kakehashi, Akihiro [1 ]
Takano, Hiroko [1 ]
Kinoshita, Nozomi [1 ]
Shimmura-Tomita, Machiko [1 ]
Ota, Ayumi [1 ]
Tanaka, Yoshiaki [1 ]
Matsumoto, Takafumi [2 ]
Tsuji, Junichi [2 ]
机构：
[1] Jichi Med Univ, Saitama Med Ctr, Dept Ophthalmol, Saitama, Japan
[2] Dainippon Sumitomo Pharma Co Ltd, Drug Dev Res Labs, Osaka, Japan
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2014年 / 55卷 / 13期
关键词：
499 diabetic retinopathy; 615; neuroprotection; 554; immunohistochemistry;
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
1060
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Effect of Ranirestat, a New Aldose Reductase Inhibitor, on Diabetic Retinopathy in SDT Rats
    Toyoda, Fumihiko
    Tanaka, Yoshiaki
    Ota, Ayumi
    Shimmura, Machiko
    Kinoshita, Nozomi
    Takano, Hiroko
    Matsumoto, Takafumi
    Tsuji, Junichi
    Kakehashi, Akihiro
    [J]. JOURNAL OF DIABETES RESEARCH, 2014, 2014
  • [2] Ranirestat as a therapeutic aldose reductase inhibitor for diabetic complications
    Giannoukakis, Nick
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2008, 17 (04) : 575 - 581
  • [3] Effects of Long-Term Treatment with Ranirestat, a Potent Aldose Reductase Inhibitor, on Diabetic Retinopathy and Neuropathy in Spontaneously Diabetic Toni Rats
    Kakehashi, Akihiro
    Takezawa, Mikiko
    Toyoda, Fumihiko
    Kinoshita, Nozomi
    Kambara, Chiho
    Yamagami, Hiroko
    Obata, Hiroto
    Matsumoto, Takafumi
    Tsuji, Junichi
    Dobashi, Hiroshi
    Kawakami, Masanobu
    Kanazawa, Yasunori
    [J]. DIABETES, 2010, 59 : A273 - A273
  • [4] DIABETIC-LIKE RETINOPATHY IN RATS PREVENTED WITH AN ALDOSE REDUCTASE INHIBITOR
    ROBISON, WG
    NAGATA, M
    LAVER, N
    HOHMAN, TC
    KINOSHITA, JH
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1989, 30 (11) : 2285 - 2292
  • [5] Drug evaluation: Ranirestat - an aldose reductase inhibitor for the potential treatment of diabetic complications
    Giannoukakis, Nick
    [J]. CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2006, 7 (10) : 916 - 923
  • [6] Long term treatment with ranirestat, an aldose reductase inhibitor, suppresses diabetic neuropathy and cataract formation in rats
    Matsumoto, Takafumi
    Toyosawa, Kaoru
    Furutani, Yasur
    Bril, Vera
    [J]. DIABETES, 2006, 55 : A125 - A125
  • [7] EFFECT OF A NEW POTENT ALDOSE REDUCTASE INHIBITOR, TAT ON DIABETIC NEUROPATHY OF RATS
    HOTTA, N
    KAKUTA, H
    KOH, N
    SAKAKIBARA, F
    KOMORI, H
    INUKAI, S
    NAITO, S
    SAKAMOTO, N
    [J]. DIABETOLOGIA, 1992, 35 : A151 - A151
  • [8] EFFECTS OF A NEW ALDOSE REDUCTASE INHIBITOR ON DIABETIC COMPLICATIONS IN RATS
    GERVASI, GB
    BARTOLI, C
    CATALANI, R
    FARINA, C
    CARPITA, G
    CACCIA, G
    AMMANNATI, P
    [J]. ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1991, 41-2 (11): : 1160 - 1163
  • [9] THE EFFECT OF AN ALDOSE REDUCTASE INHIBITOR (EPALRESTAT) ON DIABETIC NEPHROPATHY IN RATS
    ITAGAKI, I
    SHIMIZU, K
    KAMANAKA, Y
    EBATA, K
    KIKKAWA, R
    HANEDA, M
    SHIGETA, Y
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 1994, 25 (03) : 147 - 154
  • [10] Effects of aldose reductase inhibitor in diabetic rats
    Nagai, T
    Sekizuka, E
    Tsukada, K
    Shimizu, T
    Minamitani, H
    Hokari, R
    Oshio, C
    [J]. PROCEEDINGS OF THE 20TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOL 20, PTS 1-6: BIOMEDICAL ENGINEERING TOWARDS THE YEAR 2000 AND BEYOND, 1998, 20 : 3098 - 3099
12345